Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use

PURPOSE: Safely postponing the use of chemotherapy is important for quality of life maintenance in patients with hormone receptor-positive advanced breast cancer. In previous studies, a combination of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) and fulvestrant prolonged the time to chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yuka, Yoshimura, Akiyo, Sawaki, Masataka, Hattori, Masaya, Kotani, Haruru, Kataoka, Ayumi, Horisawa, Nanae, Ozaki, Yuri, Nozawa, Kazuki, Takatsuka, Daiki, Isogai, Ayaka, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411029/
https://www.ncbi.nlm.nih.gov/pubmed/36031754
http://dx.doi.org/10.4048/jbc.2022.25.e34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411029/
https://www.ncbi.nlm.nih.gov/pubmed/36031754
http://dx.doi.org/10.4048/jbc.2022.25.e34

Ejemplares similares